| Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI) (NCT02501018) | Lisata Therapeutics, Inc. | 2017-11-01 |
| Pars Plana Ex-Press Shunt in Vitrectomized Eyes (NCT03605823) | Cairo University | 2017-11-01 |
| Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency (NCT03346967) | Vinmec Research Institute of Stem Cell and Gene Technology | 2017-11-01 |
| A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma (NCT03234595) | Everfront Biotech Co., Ltd. | 2017-11-01 |
| Efficacy of Proton Pump Inhibitors in Gastrointestinal Erosions and/or Ulcers (NCT03315676) | Shinshu University | 2017-11-01 |
| Atezolizumab Immunotherapy in Patients With Advanced NSCLC (NCT03102242) | Alliance Foundation Trials, LLC. | 2017-11-01 |
| Medication Development in Alcoholism: Apremilast Versus Placebo (NCT03175549) | The Scripps Research Institute | 2017-11-01 |
| Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children (NCT03147690) | David Mooney | 2017-11-01 |
| S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites (NCT03990103) | China Medical University, China | 2017-11-01 |
| Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication (NCT03318484) | First Affiliated Hospital of Harbin Medical University | 2017-11-01 |
| Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients. (NCT03577535) | Catalysis SL | 2017-11-01 |
| Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase (NCT03050476) | Alloksys Life Sciences B.V. | 2017-11-01 |
| Study to Evaluate the Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Upper or Lower Extremity Muscles Most Affected in Subjects With ALS (NCT03338114) | Flex Pharma, Inc. | 2017-11-01 |
| Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC (NCT03075423) | Goethe University | 2017-11-01 |
| The Effect of Norepinephrine Versus Dopamine in Renal Transplant Recipients on Postoperative Graft Function (NCT03107858) | Assiut University | 2017-11-01 |
| Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules. (NCT03319043) | Shanghai University of Traditional Chinese Medicine | 2017-11-01 |
| Prospective Clinical Surveillance With Application of Trigger Tools in Critically Ill Patients (NCT03781713) | Hospital Sao Domingos | 2017-11-01 |
| Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer (NCT03126812) | The Netherlands Cancer Institute | 2017-11-01 |
| Study of Nicotinamide in Early Onset Preeclampsia (NCT03419364) | University of North Carolina, Chapel Hill | 2017-11-01 |
| Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection (NCT03147859) | Ottawa Hospital Research Institute | 2017-11-01 |
| Cannabidiol as an Adjunctive Treatment for Bipolar Depression (NCT03310593) | Hospital de Clinicas de Porto Alegre | 2017-11-01 |
| Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis (NCT03098563) | Johns Hopkins University | 2017-11-01 |
| IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2 (NCT03194815) | University of Cambridge | 2017-11-01 |
| S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer (NCT03316326) | National Taiwan University Hospital | 2017-11-01 |
| MG4101 for Refractory or Relapsed AML (NCT03349502) | Seoul National University Hospital | 2017-11-01 |
| Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate (NCT03356444) | West China Hospital | 2017-11-01 |
| Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH) (NCT03074786) | International Partnership for Microbicides, Inc. | 2017-11-01 |
| The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With Hyperkalemia (NCT03326583) | Dominic Raj | 2017-11-01 |
| Combined Treatment With CO2 Laser and Isotretinoin for Acne Scars (NCT04870489) | Tel-Aviv Sourasky Medical Center | 2017-11-01 |
| Apatinib for Advanced Biliary Carcinoma (NCT03427242) | Fudan University | 2017-11-01 |
| Comparison of Therapeutic Effects Between Intravitreal Injection of Bevacizumab With Intravitreal Injection of Bevacizumab and Targeted Laser Photocoagulation of Non Perfused Areas of Retina in Patients With Acute Retinal Vein Occlusion (NCT03353324) | Shahid Beheshti University of Medical Sciences | 2017-11-01 |
| Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn (NCT04328636) | Sohag University | 2017-11-01 |
| Fibrates in Pediatric Cholestasis (NCT03586674) | Hoda A. Atta | 2017-11-01 |
| Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC (NCT02947113) | The Netherlands Cancer Institute | 2017-11-01 |
| Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes (NCT03343782) | Vinmec Research Institute of Stem Cell and Gene Technology | 2017-11-01 |
| LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy (NCT03255434) | Institut du Cancer de Montpellier - Val d'Aurelle | 2017-11-01 |
| Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation (NCT02580253) | Zhejiang University | 2017-11-01 |
| REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study (NCT02291809) | Immune Response BioPharma, Inc. | 2017-11-01 |
| A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA (NCT03124498) | Chuan An Biotechnology Co., Ltd. | 2017-11-01 |
| Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients? (NCT03731741) | Tanta University | 2017-11-01 |
| 'Palliative-D' Vitamin D to Palliative Cancer Patients (NCT03038516) | Region Stockholm | 2017-11-01 |
| Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis (NCT03343639) | Vyne Therapeutics Inc. | 2017-11-01 |
| A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients (NCT03284177) | Otsuka Pharmaceutical Co., Ltd. | 2017-10-31 |
| A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer (NCT03292133) | Massachusetts General Hospital | 2017-10-31 |
| A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer (NCT03144804) | Massachusetts General Hospital | 2017-10-31 |
| Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF): Dose Response (NCT02797184) | Washington University School of Medicine | 2017-10-31 |
| Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma (NCT03200847) | University of Colorado, Denver | 2017-10-31 |
| Prevention of Noise-induced Hearing Loss (NCT02049073) | Washington University School of Medicine | 2017-10-31 |
| FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status (NCT03142516) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2017-10-31 |
| An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta (NCT03216486) | Ultragenyx Pharmaceutical Inc | 2017-10-31 |
| EPO-4-Rhesus Study (NCT03104426) | Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research | 2017-10-31 |
| Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy (NCT03223662) | National Cancer Institute (NCI) | 2017-10-31 |
| A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis (NCT03222609) | AbbVie | 2017-10-31 |
| Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis (NCT03218917) | Insmed Incorporated | 2017-10-31 |
| Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14 (NCT03404856) | Orpha Labs | 2017-10-31 |
| Aesculus Hippocastanum L. on Fontan Circulation (NCT04035317) | Casa Espirita Terra de Ismael | 2017-10-31 |
| A Study to Evaluate the Safety and Efficacy of TS-091 in Patients with Narcolepsy (NCT03267303) | Taisho Pharmaceutical Co., Ltd. | 2017-10-31 |
| Combined LDR Boost and HDR Whole Gland (NCT03323879) | Sunnybrook Health Sciences Centre | 2017-10-30 |
| Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759 (NCT03360929) | LYZZ Alpha Holding Ltd | 2017-10-30 |
| Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata. (NCT03325296) | LEO Pharma | 2017-10-30 |
| Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India (NCT03474055) | Serum Institute of India Pvt. Ltd. | 2017-10-30 |
| Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea (NCT03263273) | Hovione Scientia Limited | 2017-10-30 |
| Effect of Galantamine on Inflammation and Cognition (NCT03384784) | University of Pennsylvania | 2017-10-30 |
| Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL (NCT03319901) | Dana-Farber Cancer Institute | 2017-10-30 |
| Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) (NCT03213691) | National Cancer Institute (NCI) | 2017-10-30 |
| ONC201 in Adults With Recurrent H3 K27M-mutant Glioma (NCT03295396) | Jazz Pharmaceuticals | 2017-10-30 |
| An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab (NCT03167437) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-10-30 |
| AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD). (NCT03317002) | AstraZeneca | 2017-10-30 |
| Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine (NCT03280342) | University of Minnesota | 2017-10-30 |
| Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer (NCT03104595) | Enzychem Lifesciences Corporation | 2017-10-30 |
| Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancer (NCT03234842) | University of Florida | 2017-10-30 |
| Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (NCT03015402) | University of Pittsburgh | 2017-10-30 |
| Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging (NCT03303469) | University of Alabama at Birmingham | 2017-10-30 |
| Efficacy and Safety of TwHF and MTX in Patients With Rheumatoid Arthritis (NCT03324412) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2017-10-28 |
| A Specification Clinical Application Research of Tripterygium Wilfordii Treating Rheumatoid Arthritis (NCT03337815) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2017-10-28 |
| A Study of Acute Myocardial Infarction Using FDY-5301 (NCT03470441) | Faraday Pharmaceuticals, Inc. | 2017-10-27 |
| A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT03272503) | University of Calgary | 2017-10-27 |
| Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT03067571) | M.D. Anderson Cancer Center | 2017-10-27 |
| A Study Assessing the Efficacy and Safety of DE-127 Ophthalmic Solution in Subjects With Mild or Moderate Myopia (APPLE) (NCT03329638) | Santen Pharmaceutical Co., Ltd. | 2017-10-27 |
| The Combination Therapy With Ra-223 and Enzalutamide (NCT03305224) | Taro Iguchi, MD, PHD | 2017-10-27 |
| Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer (NCT02961374) | National Cancer Institute (NCI) | 2017-10-27 |
| Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure (NCT03525379) | University of Alberta | 2017-10-26 |
| Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction (NCT02703662) | University of Calgary | 2017-10-26 |
| Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension (NCT03029416) | Ronald McGarry | 2017-10-26 |
| Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) (NCT03203473) | Toni Choueiri, MD | 2017-10-26 |
| Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction (NCT03274752) | Insel Gruppe AG, University Hospital Bern | 2017-10-26 |
| Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629) (NCT03284424) | Merck Sharp & Dohme LLC | 2017-10-26 |
| SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC) (NCT03050554) | Andrew Sharabi | 2017-10-26 |
| A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia (NCT03271541) | Hoffmann-La Roche | 2017-10-26 |
| Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat (NCT03224117) | Daewoong Pharmaceutical Co. LTD. | 2017-10-26 |
| Priming Immunotherapy in Advanced Disease With Radiation (NCT03313804) | John L. Villano, MD, PhD | 2017-10-26 |
| Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer (NCT03289039) | Dana-Farber Cancer Institute | 2017-10-25 |
| A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA (NCT03316131) | AstraZeneca | 2017-10-25 |
| Evaluation of TTP399 in Patients With Type 1 Diabetes (NCT03335371) | vTv Therapeutics | 2017-10-25 |
| A Study Of Daratumumab, Low-Dose Oral Dexamethasone and Cyclophosphamide With Or Without Pomalidomide (NCT03215524) | Canadian Myeloma Research Group | 2017-10-25 |
| Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen (NCT03279289) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2017-10-25 |
| Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents (NCT03227146) | CUTISS AG | 2017-10-25 |
| ET-01 in Subjects With Lateral Canthal Lines (NCT03326856) | Eirion Therapeutics Inc. | 2017-10-25 |
| A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors (NCT03261947) | Millennium Pharmaceuticals, Inc. | 2017-10-25 |
| Topical Chemoprevention of Skin Cancer Biomarkers (NCT02636569) | University of Alabama at Birmingham | 2017-10-25 |